Cardiorenal benefits of glucagon-like peptide-1 analogues vs. exendin-4 analogues in patients with type 2 diabetes: a meta-analysis based on cardiovascular outcome trials-MedSci.cn

Cardiorenal benefits of glucagon-like peptide-1 analogues vs. exendin-4 analogues in patients with type 2 diabetes: a meta-analysis based on cardiovascular outcome trials

Qiu, M; Wei, XB; Wei, W

Qiu, M (通讯作者)，Shenzhen Longhua Dist Cent Hosp, Dept Gen Med, Guanlan Ave 187, Shenzhen 518110, Peoples R China.